tHEORetically speaking: EU HTA Joint Clinical Assessments
Update: 2024-03-14
Description
In this episode of tHEORetically Speaking, join Dr. Rosemary Jose, Dr. Sonja Kroep, and Nick Halfpenny from OPEN Health, Dr. Ansgar Hebborn from Roche, and James Ryan from AstraZeneca, who answer questions from a recent webinar on several policy aspects regarding the current challenges and implications of the EU Health Technology Assessment (HTA) regulation.
For more information, to watch the webinar, or access other resources, click here.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
